Status:
UNKNOWN
Intravenous Dexmeditomidine for Prevention of Spinal Anesthesia Induced Shivering.
Lead Sponsor:
Rehman Medical Institute - RMI
Conditions:
Postoperative Shivering
Cesarean Delivery
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
Intraoperative and post operative shivering is a common problem encountered in operating rooms and recovery suites. Shivering under spinal anesthesia has an incidence of 40-60%. Shivering is not only ...
Detailed Description
Intraoperative inadvertent changes in the body temperature are quite common. Incidence of inadvertent hypothermia (up to 90%) is much higher than hyperthermia. The hypothermic patients shiver postoper...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- American Society of Anesthesiologists (ASA) physical status I and II ladies
- Singleton pregnancies.
- Undergoing elective Cesarean delivery under spinal anesthesia.
- Systolic blood pressure ≥ 100 mm of Hg after umbilical cord clamping
- Exclusion criteria:
- ASA class III or above
- Hyperthyroidism
- Cardiopulmonary or respiratory disease
- A psychological disorder
- An initial body temperature of \>37.5 °C or \<36.5 °C
- Systolic blood pressure \<100 mm of Hg after umbilical cord clamping and/or mean arterial pressure (MAP) \< 65 mm of Hg after umbilical cord clamping
Exclusion
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05342376
Start Date
February 1 2022
End Date
December 31 2022
Last Update
May 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rehman Medical Institute
Peshawar, Khyber Pakhtunkhwa, Pakistan, 25000